ENTITY

Revelation Biosciences (REVB US)

13
Analysis
Health Care • United States
Revelation Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapeutics and diagnostics for viral infections by harnessing the power of the innate immune system. Revelation Biosciences serves customers worldwide.
more
•30 Apr 2025 00:00•Issuer-paid

REVB: New Target Market Announced

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•18 Mar 2025 00:00•Issuer-paid

REVB: Study Shows Positive Results

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•08 Mar 2025 00:00•Issuer-paid

REVB: 2025 Is the Year for Measurable Progress

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•03 Dec 2024 04:00•Issuer-paid

REVB: Phase 1b Study Cleared

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•12 Nov 2024 01:00•Issuer-paid

REVB: Good Expense Control as Company Prepares for Trials

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
x